Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2014 | 02-2014 | 12-2013 | 03-2013 | 02-2013 | |
| Sales | 470 | 0 | 470 | 720 | 0 |
| Cost of Goods | 270 | N/A | 270 | 400 | N/A |
| Gross Profit | 200 | N/A | 200 | 310 | N/A |
| Operating Expenses | 10,800 | 0 | 10,530 | 7,700 | 0 |
| Operating Income | -10,330 | N/A | -10,330 | -6,980 | N/A |
| Interest Expense | 0 | 0 | 0 | 3 | 0 |
| Other Income | -780 | 0 | -780 | 83 | 0 |
| Pre-tax Income | -11,110 | 0 | -11,110 | -6,900 | 0 |
| Net Income Continuous | -11,612 | N/A | -11,612 | -6,905 | N/A |
| Net Income | $-11,110 | $N/A | $-11,110 | $-6,900 | $N/A |
| EPS Basic Total Ops | -67.19 | N/A | -1.40 | -43.19 | N/A |
| EPS Basic Continuous Ops | -67.20 | N/A | -1.40 | -45.55 | N/A |
| EPS Diluted Total Ops | -67.19 | N/A | -1.40 | -43.19 | N/A |
| EPS Diluted Continuous Ops | -67.20 | N/A | -1.40 | -45.55 | N/A |
| EBITDA(a) | $-8,640 | $N/A | $-9,050 | $-6,320 | $N/A |